Well Told Grants

Federal grant recipients / New York

Federal grants to Ascribe Bioscience Inc.

Ithaca, New York · Small businesses · UEI K17YGJXFWM95

Ascribe Bioscience Inc. in Ithaca, New York received $3.7 million in federal grants from fiscal 2021 to 2025, across 3 awards. Its largest program was Allergy and Infectious Diseases Research, with $3.1 million. It had no new grant money in fiscal 2025.

From USAspending.gov award records, updated October 31, 2026.

By year

Federal grants to Ascribe Bioscience Inc. by fiscal year
Fiscal yearAwardsAmount
FY 20210$0
FY 20222$1.3 million
FY 20232$1.1 million
FY 20242$1.3 million
FY 20250$0

An award funded in several years counts in each of them, so yearly awards add up to more than the five-year total.

Programs that fund Ascribe Bioscience Inc.

Every program, fiscal 2021 to 2025
ProgramAwardsAmount
Allergy and Infectious Diseases Research 93.8552$3.1 million
Technology, Innovation, and Partnerships 47.0841$649,007

Awarding agencies

AgencyAwardsAmount
Department of Health and Human Services2$3.1 million
National Science Foundation1$649,007

Largest awards

The 3 largest awards by money obligated in fiscal 2021 to 2025
AwardProgramFirst actionAmount
Preventing outbreaks of foodborne pathogenic bacteria in edible sprouts via novel resistance-conferring seed treatments - abstract ascribe bioscience is developing a novel technology to prevent foodborne outbreaks caused by the consumption of edible sprouts. Sprouts are highly vulnerable to infectio
ASST_NON_R44AI152915_075 on USAspending
Allergy and Infectious Diseases ResearchMarch 10, 2022$2.8 million
Sbir phase II: controlling plant pathogens with novel seed treatments based on nematode-produced ascarosides
ASST_NON_1951164_049 on USAspending
Technology, Innovation, and PartnershipsNovember 1, 2022$649,007
Using novel pre-harvest, resistance-conferring treatments to prevent foodborne pathogenic outbreaks in produce - abstract - ascribe bioscience is developing a novel technology to prevent foodborne outbreaks and recalls caused by the consumption of fresh or minimally processed fruits and vegetables.
ASST_NON_R41AI170268_075 on USAspending
Allergy and Infectious Diseases ResearchJuly 25, 2022$299,999

Amounts are net obligations: money committed, minus any amounts taken back. They are not payments. See how our data works.

Questions people ask

How much federal grant money does Ascribe Bioscience Inc. get?

$3.7 million in 3 grant awards from fiscal 2021 to 2025, as obligations reported to USAspending.gov.

Which agency gives Ascribe Bioscience Inc. the most?

The Department of Health and Human Services, with $3.1 million in 2 awards. The National Science Foundation follow.

What is Ascribe Bioscience Inc.'s largest federal grant?

$2.8 million under Allergy and Infectious Diseases Research, with its first action in the period on March 10, 2022. That counts only the money obligated in fiscal 2021 to 2025.

Which federal programs fund Ascribe Bioscience Inc.?

Its largest are Allergy and Infectious Diseases Research and Technology, Innovation, and Partnerships.

Other grant recipients in Ithaca

Largest federal grant recipients in New York · Federal grants in New York